Evidence map›Paper›PMID 41251145›Full record

ArticleQualitative health research2026

Patient Perspectives on Trust in Artificial Intelligence-Powered Tools in Prostate Cancer Diagnostics.

Simon Aleksander Berger, Erna Håland, Marit Solbjør

Abstract read
In one paragraph

Article in Qualitative health research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Simon Aleksander BergerDepartment of Education and Lifelong Learning, Faculty of Social and Educational Sciences, Norwegian University of Science and Technology, Trondheim, Norway.ORCID 0009-0009-7762-8377
Erna HålandDepartment of Education and Lifelong Learning, Faculty of Social and Educational Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Marit SolbjørDepartment of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.ORCID 0000-0001-8959-4076

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing prevalence of prostate cancer cases calls for new ways to improve diagnostic pathways and patient care. Artificial intelligence (AI)-powered tools offer potential to streamline prostate cancer diagnostics, yet little is known about how patients perceive and experience these technologies. This study investigates how patients diagnosed through an AI-powered prostate cancer diagnostic tool express trust in AI. Based on 18 semi-structured qualitative interviews with men who underwent AI-supported diagnostics, data were analyzed using reflexive thematic analysis. Three dimensions of trust were developed. First, participants described a foundational trust in the healthcare system and professionals, shaped by previous positive encounters. Second, this interpersonal trust was central to their acceptance of AI, as participants relied on healthcare professionals and their expertise to explain, justify, and endorse AI technology. Third, participants recognized AI's potential to enhance diagnostics but emphasized the demand for human oversight and second opinion, due to concerns about accountability and AI's lack of intuition and holistic clinical oversight. Participants were more forgiving of human errors than those made by AI, highlighting the relational and moral dimensions of trust in healthcare. These findings underscore the importance of human relationships in shaping how patients engage with AI technologies and how trust in healthcare professionals remains a critical mediator for acceptance of AI in clinical settings. Understanding patients' trust in AI requires attention to the sociotechnical context in which care is delivered. In conclusion, trust in healthcare professionals remains paramount and is crucial for the acceptance of AI in prostate cancer diagnostics.

Indexed as

Artificial IntelligenceProstatic NeoplasmsTrustAgedHumansInterviews as TopicMaleMiddle AgedQualitative Researchartificial intelligencedoctor–patient communicationNorwaypatient safetyprostate cancer diagnosticsqualitative interviewsreflexive thematic analysistrustusers’ experiences

Identifiers

PMID41251145
PMCPMC12949041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.